| Chairman |
|
Zhang Faming |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman: Zhang Faming
Chief Executive Officer & General Manager: Li Qixiang Henry
Executive Director: Liu Min, Xiao Jieyu
Non-executive Director: Li Jian
Independent Non-executive Director: Bi Honggang, Chen Qifeng, Wong Sai Hung, Zhang Qiongguang.
|
| Principle Business |
|
The Group is principally engaged in biopharmaceutical business, focusing on the research and development of immune-oncology therapies. |
| Major Shareholders |
| Zhang Faming & ASSO | 76,138,710 | H Sh | 55.89% | 55.89% | 2025/12/23 | | Yu Zhihua | 14,652,130 | H Sh | 10.76% | 10.76% | 2025/12/23 | | Hangzhou Hongye Ruiji Investment Partnership (Limited Partnership) | 12,860,470 | H Sh | 9.44% | 9.44% | 2025/12/23 |
|
|
|
|
|